Under 35 U.S.C. 102, novelty means that no single prior public disclosure already describes your invention as of your patent application’s effective filing date. If one earlier reference — a patent, a publication, a public use, a sale, or any other public availability — contains every element of a claim arranged the same way, the claim is “anticipated” and cannot be patented. Everything else in Section 102 is either a definition of what counts as that prior disclosure or a narrow exception that pulls certain disclosures back out of the pool.
How the Novelty Test Works
Examiners evaluate each claim on its own. A claim fails only if a single prior art reference discloses every element. If even one element is missing from the reference, the claim survives the novelty analysis, though it may still face a separate obviousness challenge under 35 U.S.C. 103.
The benchmark date is your effective filing date. Anything publicly available before that date is fair game against you. Since the America Invents Act took effect on March 16, 2013, the United States has operated on a first-inventor-to-file basis, so priority goes to whoever files first, not whoever conceived the idea first.1Federal Register. Changes To Implement the First Inventor To File Provisions of the Leahy-Smith America Invents Act Waiting exposes you to two risks at once: your own later disclosures and someone else’s earlier filing.
A provisional application is the standard tool for pulling your effective filing date earlier. It must describe the invention thoroughly enough that a person skilled in the field could reproduce it, and you must file the non-provisional within 12 months with a specific reference back, or you lose the earlier date.2Office of the Law Revision Counsel. 35 USC 119 Benefit of Earlier Filing Date Right of Priority An unintentional miss can be cured within two months by paying an additional fee and showing the delay was not deliberate.
What Counts as Prior Art Under Section 102
Section 102 divides prior art into two categories. Under 102(a)(1), anything patented, described in a printed publication, in public use, on sale, or otherwise available to the public before your effective filing date can defeat novelty. Under 102(a)(2), a patent or published application filed by a different inventor before your effective filing date also counts, even if it is not published or granted until later.3Office of the Law Revision Counsel. 35 USC 102 Conditions for Patentability Novelty
That second bucket is the one that surprises applicants. Someone else’s application, sitting invisibly in the USPTO’s queue, becomes prior art against you as of its filing date once it eventually publishes (typically 18 months after filing). By the time it appears in a search, your window may already be gone.
Patents and Publications
Granted patents and published applications, domestic or foreign, are the most straightforward prior art. Obscurity is no defense: the Supreme Court held in Hazeltine Research, Inc. v. Brenner that a prior patent need not be widely known to block a later application.4Justia U.S. Supreme Court Center. Hazeltine Research Inc v Brenner 382 US 252 (1965) Courts also read “printed publication” broadly. Journal articles, conference papers, books, dissertations, blog posts, and archived web pages all qualify if someone working in the field could locate them through reasonable effort.
Public Use and Sales
An invention used publicly or offered for sale before the filing date creates prior art even without any written description. A single unrestricted use can be enough. In Egbert v. Lippmann, the Supreme Court found a public use where the inventor gave the invention privately to one person who then used it openly.5Justia U.S. Supreme Court Center. Egbert v Lippmann 104 US 333 (1881)
The on-sale bar is where inventors get caught most often. In Pfaff v. Wells Electronics, the Supreme Court set a two-part test: the invention must be ready for patenting, and it must be the subject of a commercial offer for sale. Ready for patenting means either reduced to practice or documented in drawings and descriptions detailed enough for someone skilled in the field to build it. You do not have to deliver the product or close the deal; a firm offer starts the clock.6Cornell Law School. Pfaff v Wells Electronics Inc
The 2019 decision in Helsinn Healthcare v. Teva Pharmaceuticals tightened this further. The Court held unanimously that even a confidential sale triggers the on-sale bar. A contractual obligation to keep the invention secret did not save the patent; the commercial transaction itself was enough.7Justia U.S. Supreme Court Center. Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc 586 US (2019) Inventors who assume an NDA protects their patent rights during negotiations often learn this the hard way.
Other Public Disclosures
Oral presentations, trade show exhibits, and product demonstrations can each create prior art if they reveal enough for someone to reproduce the invention. In Minnesota Mining & Manufacturing v. Chemque, a trade show demonstration was treated as a public disclosure.8Justia Law. Minnesota Mining and Manufacturing Co v Chemque Inc 303 F3d 1294 (Fed Cir 2002) In Cordis Corp. v. Boston Scientific, a medical device prototype shown to physicians without confidentiality agreements became prior art.9Justia Law. Cordis Corp v Boston Scientific Corp 561 F3d 1319 (Fed Cir 2009) Before showing an invention to anyone outside your organization, get a written confidentiality agreement in place.
The One-Year Grace Period
Section 102(b)(1) gives inventors a 12-month safety net. If you publicly disclose your own invention — through publication, presentation, sale, or otherwise — you have one year from that disclosure to file without the disclosure counting against you.10Office of the Law Revision Counsel. 35 USC 102 Conditions for Patentability Novelty
The protection is narrower than it looks. It covers disclosures that originate from you or from someone who got the information from you. If an unrelated third party independently comes up with the same idea and publishes it during your grace period, the grace period does nothing. The Federal Circuit in Dynamic Drinkware v. National Graphics emphasized that the applicant carries the burden of tracing the disclosure back to the inventor.11United States Court of Appeals for the Federal Circuit. Dynamic Drinkware LLC v National Graphics Inc
There is a competitive risk baked in as well. If you give a talk in month one and file in month eleven, a competitor who files independently during those ten months creates a serious dispute. Treat the grace period as a rescue for accidental or premature disclosures, not as a filing schedule.
The Experimental Use Exception
Not every pre-filing use destroys novelty. Public testing done genuinely to evaluate whether the invention works can qualify as experimental use rather than invalidating public use. In City of Elizabeth v. American Nicholson Pavement Co., the Supreme Court allowed a patent on a road surface that had been tested on a public street for years, because the inventor maintained control, monitored results, and made improvements based on the observations.12Justia U.S. Supreme Court Center. City of Elizabeth v American Nicholson Pavement Co 97 US 126 (1877)
The exception is narrow. Courts look at what actually happened rather than the inventor’s stated purpose. Factors include whether the inventor kept the invention under personal control, whether the testing served a genuine developmental purpose, and whether third parties were allowed to use or sell the invention freely. Profit-taking during the “test” tends to defeat the argument. Testing logs, protocols, and access restrictions all strengthen the case.
The Joint Research Agreement Carve-Out
Collaborations create their own prior art risks. Section 102(c) treats certain disclosures within a joint research agreement as if they came from a single entity, removing them from the prior art analysis.13Office of the Law Revision Counsel. 35 USC 102 Conditions for Patentability Novelty Three conditions apply. The agreement must be a written contract in effect on or before the effective filing date. The invention must have come out of work within the agreement’s scope. And the patent application must name the parties to the agreement. Informal collaborations do not qualify, so a written joint research agreement should be signed before any inventive work begins.
Novelty Is Not the Same as Obviousness
Applicants routinely conflate these two grounds, and the strategies for beating each are different. Section 102 asks whether a single reference describes your invention. Section 103 asks whether the differences between your invention and the prior art would have been obvious to someone with ordinary skill in the field, and it allows multiple references to be combined against you.14USPTO. 2151 Overview of the Changes to 35 USC 102 and 103 in the AIA Adding a new element to overcome anticipation does not guarantee you overcome obviousness, because an examiner can then argue that combining the old elements with the new one would have been obvious.
Responding to a Section 102 Rejection
An anticipation rejection means the examiner has identified a single reference allegedly disclosing every element of your claim. The mechanics of the rule tell you how to fight back: show that the reference does not actually disclose every element.
Amending claims is the standard move. If the cited reference describes elements A, B, and C, add element D that is genuinely present in your invention but absent from the reference. Or narrow a broad claim to exclude the specific thing the reference discloses. Break the single-reference chain and the rejection fails.15USPTO. Anticipation – Application of 35 USC 102
Arguments that work against obviousness do not work here. Commercial success, unexpected results, industry praise, references from unrelated fields, and “teaching away” arguments are all irrelevant to a Section 102 rejection. If the reference discloses the elements, it anticipates the claim regardless of context. Applicants who confuse the two statutes waste time making the wrong arguments.
Filing Abroad Changes the Calculus
The one-year grace period is a U.S. feature. Most major jurisdictions apply an absolute novelty standard, so any public disclosure before your filing date — including your own — can permanently eliminate patent rights there. The European Patent Office offers no grace period. Japan provides a limited six-month window in narrow circumstances. If foreign protection is a possibility, file before you disclose. A provisional application can establish the date and give you 12 months to pursue Patent Cooperation Treaty or direct national filings. Relying on the U.S. grace period as a global safety net is one of the more expensive mistakes an inventor can make.